eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Rosemont Pharmaceuticals Limited

Rosemont House, Yorkdale Industrial Park, Braithwaite Street, Leeds, Yorkshire, LS11 9XE
Telephone: +44 (0)113 244 1400
Fax: +44 (0)113 246 0738
WWW: http://www.rosemontpharma.com
Customer Care direct line: +44 (0)800 919 312
Out of Hours Telephone: +44 (0)7836 557 879
Out of Hours contact: pharmacovigilance@rosemontpharma.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Summary of Product Characteristics last updated on the eMC: 13/01/2012
SPC Paracetamol 120mg/5ml Oral Suspension

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 13/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.4 - Special warnings and precautions for Use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.8 - Undesirable Effects
  • Change to section 6. 4 - Special Precautions for Storage
  • Change to section 6. 5 - Nature and Contents of Container
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   05-Dec-2011
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company



4.2.            Posology and Method of Administration

 

The following text has been added:

 

It is important to shake the bottle for at least 10 seconds before use

 

Age

Dose

For post-vaccination fever for babies aged between 2 – 3 months

 

One 2.5 mL spoonful (small end)

If necessary, after 4-6 hours, give a second 2.5 mL dose

  • Do not give to babies less than 2 months of age
  • Do not give more than 2 doses
  • Leave at least 4 hours between doses
  • If further doses are needed, talk to your doctor or pharmacist

 

Child’s Age

How Much

How often (in 24 hours)

3 – 6 months

One 2.5 mL spoonful (small end)

4 times

6 – 24 months

One 5 mL spoonful (large end)

4 times

2 – 4 years

One 5.0 mL spoonful (large end) and one 2.5 mL spoonful (small end)

4 times

4 – 8 years

Two 5 mL spoonfuls (large end)

4 times

8 – 10 years

Three 5 mL spoonfuls (large end)

4 times

10 - 12 years

Four 5 mL spoonfuls (large end)

4 times

  • Do not give more than 4 doses in any 24 hour period
  • Leave at least 4 hours between doses
  • Do not give this medicine to your child for more than 3 days without speaking to your doctor or pharmacist

 

4.4.      Special Warnings and Special Precautions for Use

 

Text in red has been added:

 

  • Contains paracetamol.
  • Do not give with any other paracetamol-containing products.
  • For oral use only.
  • Never give more medicine than shown in the table.
  • Always use the spoon supplied with the pack.  Do not overfill the spoon.
  • Do not give to babies less than 2 months of age.
  • For infants 2-3 months no more than 2 doses should be given.
  • Do not give more than 4 doses in any 24 hour period.
  • Leave at least 4 hours between doses.
  • Do not give this medicine to your child for more than 3 days without speaking to your doctor or pharmacist.
  • As with all medicines, if your child is currently taking any medicine consult your doctor or pharmacist before taking this product.
  • Do not store above 25°C. Protect from light. Store in the original package.
  • Immediate medical advice should be sought in the event of an overdose, even if the child seems well, because of the risk of delayed serious liver damage.
  • If symptoms persist consult your doctor.
  • Keep out of the reach and sight of children.

 

4.5.      Interactions with other medicinal products and other forms of interaction

 

The following text has been added:

 

The use of drugs that induce hepatic microsomal enzymes such as anticonvulsants and oral contraceptives may increase the extent of metabolism of paracetamol resulting in reduced plasma concentrations of the drug and a faster elimination rate.

 

4.8.      Undesirable Effects

 

The following text has been added:

 

Chronic hepatic necrosis has been reported in a patient who took daily therapeutic doses of paracetamol for about a year and liver damage has been reported after daily ingestion of excessive amounts for shorter periods. A review of a group of patients with chronic active hepatitis failed to reveal differences in the abnormalities of liver function in those who were long-term users of paracetamol nor was the control of the disease improved after paracetamol withdrawal.

 

 

6.4.      Special Precautions for Storage

 

Text in red has been added:

 

Store below 25°C. Protect from light. Store in the original package.

 

 

6.5.      Nature and Contents of Container

 

Text in red has been added:

 

Amber (Type III) glass bottle with capacity of 60ml, 100ml, 125ml, 500ml and 1000ml.

Closure:            1. Aluminium, wadded, roll-on, pilfer proof closure.

                                    2. HDPE, child resistant, tamper evident, EPE wadded closure

                                    3. HDPE, tamper evident, EPE wadded closure.

Dosing device: 2.5/5ml double ended polypropylene spoon.

 

10.       Date of (Partial) Revision of the Text

           

            05 December 2011

 

 

 

 

Updated on 25/11/2009 and displayed until 13/01/2012
Reasons for adding or updating:
  • Change to section 1 -Name of the Medicinal product
Date of revision of text on the SPC:   02-Oct-2009
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

In Section 1.0 (Trade Name of the Medicinal Product), the name has been changed from Paldesic 120mg/5ml Oral Suspension to Paracetamol 120mg/5ml Oral Suspension.
Updated on 29/10/2008 and displayed until 25/11/2009
Reasons for adding or updating:
  • Change to section 1 -Name of the Medicinal product
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   01-Jul-2008
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 1: Re-arranged product name as per current guidance
Updated on 26/07/2005 and displayed until 29/10/2008
Reasons for adding or updating:
  • Change to section 4.9 - Overdose
  • Change to section 10 (date of (partial) revision of the text
Updated on 27/09/2002 and displayed until 26/07/2005
Reasons for adding or updating:
  • New SPC for new product

Active Ingredients/Generics

 
   paracetamol